Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease

References

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31.
   PubMed Web of Science ®Google Scholar
• Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2004;2:1048–58.
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009;49:306–17.
   PubMed Web of Science ®Google Scholar
• Bravo A, Sheth S, Chopra S. Liver biopsy. N Engl J Med 2001;344:495–500.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898–906.
   PubMed Web of Science ®Google Scholar
• Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient echo and fat-saturated fast spin-echo techniques – initial experience. Radiology 2005;237:507–11.
   PubMed Web of Science ®Google Scholar
• Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol 2005;29:1143–7.
   PubMedGoogle Scholar
• Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189–94.
   PubMed Web of Science ®Google Scholar
• Glover GH. Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1991;5:521–30.
   Google Scholar
• Bley TA, Wieben O, François CJ, Brittain JH, Reeder SB. Fat and water magnetic resonance imaging. J Magn Reson Imaging 2010;31:4–18.
   PubMedGoogle Scholar
• Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 2010;18:337–57.
   PubMedGoogle Scholar
• Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729–49.
   PubMed Web of Science ®Google Scholar
• Reeder SB, Robson PM, Yu H, Schimakawa A, Hines CD, McKenzie CA, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009;29:1332–9.
   PubMedGoogle Scholar
• Yokoo T, Bydder M, Hamilton G, Middelton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009;251:67–76.
   PubMedGoogle Scholar
• Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, Petersen KF, et al. Comparative MR study of hepatic fat quantification using single voxel proton spectroscopy, two point Dixon and three-point IDEAL. Magn Reson Med 2008;59:521–7.
   PubMed Web of Science ®Google Scholar
• Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22–9.
   PubMed Web of Science ®Google Scholar
• Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422–31.
   PubMed Web of Science ®Google Scholar
• Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267:767–75.
   PubMed Web of Science ®Google Scholar
• Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial. Hepatology 2013;58:1930–40.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report of a WHO consultation: definition of metabolic syndrome in definition, diagnosis and classification of diabetes mellitus. Geneva: World Health organization, Department of Noncommunicable Disease Surveillance; 1999.
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta ML, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beattu BJ, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007;26:1153–61.
   PubMed Web of Science ®Google Scholar
• Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103–7.
   PubMed Web of Science ®Google Scholar
• Kukkonen K, Rauramaa R, Siitonen O, Hänninen O. Physical training of obese middle-aged persons. Ann Clin Res 1982;34:80–5.
   Google Scholar
• Bydder M, Shiehmorteza M, Yokoo T, Sugay S, Middleton MS, Girard O, et al. Assessment of liver fat quantification in the presence of iron. Magn Reson Imaging 2010;28:767–76.
   PubMed Web of Science ®Google Scholar
• Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5:281–5.
   PubMed Web of Science ®Google Scholar
• Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001;221:740–6.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved non-alcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003;38:1008–17.
   PubMed Web of Science ®Google Scholar
• Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with non-alcoholic steatohepatitis. N Engl J Med 2006;355:2297–307.
   PubMed Web of Science ®Google Scholar
• Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2004;19:537–44.
   PubMed Web of Science ®Google Scholar
• Idilman R, Mizrak D, Corapcioglu D, Bektas M, Doganay B, Sayki M, et al. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008;28:200–8.
   PubMed Web of Science ®Google Scholar
• Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119–28.
   PubMed Web of Science ®Google Scholar
• Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121–9.
   PubMed Web of Science ®Google Scholar
• Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132–8.
   PubMed Web of Science ®Google Scholar
• Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013;59:550–6.
   PubMed Web of Science ®Google Scholar